Latest market price
74.85
+0.65+0.88%
OverviewShort InterestFilings
TARSQT62Tarsus Pharmaceuticals, Inc.·NASDAQ
74.85+0.88%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 13, 20268-K/ACurrent report (amended)
Oct 13, 2026S-3ASRS-3ASR
Oct 13, 2026S-3ASRS-3ASR
Sep 17, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 10, 20268-KCurrent report
Sep 09, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 20268-KCurrent report
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 13, 20268-KCurrent report
Jul 08, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
#1 / 25 of 461
Page
▼
/ 19